Across Maasai country in Kenya and Tanzania, plant medicine remains part of a living system of care. Families may know plants used for stomach complaints, coughs, wounds, pain, dental hygiene or general strength. Specialists may be consulted when an illness is serious, while clinics and hospitals are also part of the choices people make.
The question is no longer whether this knowledge exists. Ethnobotanical research has documented it extensively. The harder question is how health systems can respect Maasai expertise without turning untested remedies into prescriptions, confusing one species with another, exhausting wild plants or allowing outsiders to profit from community knowledge.
Can Maasai herbal remedies be integrated into primary healthcare? Yes, but responsible integration requires correct botanical identification, laboratory and clinical evidence, quality control, referral rules, conservation and Maasai leadership. Traditional use can guide research and culturally trusted care, yet it cannot by itself establish a remedy’s safety, dosage or effectiveness.
Who Are the Maasai?
The Maasai are an Indigenous East African people whose homeland crosses southern Kenya and northern Tanzania. Maa language, cattle keeping, age-set institutions and relationships with grazing landscapes have shaped community life, but Maasai people today include pastoralists, farmers, business owners, health workers and urban professionals. XTRAfrica’s introduction to Maasai culture, history and traditions gives the wider background.
Plant knowledge is not identical across this large region. Species vary by altitude, rainfall and habitat, while knowledge differs among localities, families, specialists, women, men and generations. Evidence from Loita, Sekenani or Monduli therefore describes those places; it should not be presented as a rule for every Maasai community.
Herbal Medicine as Everyday Primary Care
Primary healthcare begins close to where people live. In that sense, Maasai herbal practice has long operated as household and community care rather than as an isolated “alternative” system. Remedies can be gathered locally, prepared within families and used alongside foods, soups, hygiene practices or specialist consultation.
A study of 31 knowledgeable people in three Loita villages documented 62 medicinal plant species. Participants described decoctions, macerated preparations, raw plant material and external applications. When treatment did not help or a condition became complicated, people might consult an oloiboni or attend a clinic (Nankaya et al., 2020, pp. 2569, 2581–2585).
Research in Sekenani Valley produced a different local picture. Investigators collected 155 species and recorded 39 with medicinal uses. Dental cleaning, wound care, body pain and plants associated with malaria or fever appeared in the record.
AFRICAN CULTURE
Ethnobotanical Evidence: Maasai Medicinal Plants in Primary Healthcare
Jul 24, 2026
Jul 24, 2026
16 min read

Published
Updated:
Across Maasai country in Kenya and Tanzania, plant medicine remains part of a living system of care. Families may know plants used for stomach complaints, coughs, wounds, pain, dental hygiene or general strength. Specialists may be consulted when an illness is serious, while clinics and hospitals are also part of the choices people make.

The question is no longer whether this knowledge exists. Ethnobotanical research has documented it extensively. The harder question is how health systems can respect Maasai expertise without turning untested remedies into prescriptions, confusing one species with another, exhausting wild plants or allowing outsiders to profit from community knowledge.
Can Maasai herbal remedies be integrated into primary healthcare? Yes, but responsible integration requires correct botanical identification, laboratory and clinical evidence, quality control, referral rules, conservation and Maasai leadership. Traditional use can guide research and culturally trusted care, yet it cannot by itself establish a remedy’s safety, dosage or effectiveness.
Who Are the Maasai?

The Maasai are an Indigenous East African people whose homeland crosses southern Kenya and northern Tanzania. Maa language, cattle keeping, age-set institutions and relationships with grazing landscapes have shaped community life, but Maasai people today include pastoralists, farmers, business owners, health workers and urban professionals. XTRAfrica’s introduction to Maasai culture, history and traditions gives the wider background.
Plant knowledge is not identical across this large region. Species vary by altitude, rainfall and habitat, while knowledge differs among localities, families, specialists, women, men and generations. Evidence from Loita, Sekenani or Monduli therefore describes those places; it should not be presented as a rule for every Maasai community.
Herbal Medicine as Everyday Primary Care
Primary healthcare begins close to where people live. In that sense, Maasai herbal practice has long operated as household and community care rather than as an isolated “alternative” system. Remedies can be gathered locally, prepared within families and used alongside foods, soups, hygiene practices or specialist consultation.
A study of 31 knowledgeable people in three Loita villages documented 62 medicinal plant species. Participants described decoctions, macerated preparations, raw plant material and external applications. When treatment did not help or a condition became complicated, people might consult an oloiboni or attend a clinic (Nankaya et al., 2020, pp. 2569, 2581–2585).
Research in Sekenani Valley produced a different local picture. Investigators collected 155 species and recorded 39 with medicinal uses. Dental cleaning, wound care, body pain and plants associated with malaria or fever appeared in the record.
The researchers also observed that access to government care had reduced some medicinal plant use while everyday practices, including plant-based toothbrushes, remained common (Bussmann et al., 2006, pp. 1, 5).
This coexistence matters. Integration should not force patients to choose between cultural identity and biomedical treatment. It should make it easier to disclose herbal use, receive prompt diagnosis and reach higher-level care when danger signs appear. The same principle applies to changing food and health practices described in XTRAfrica’s account of traditional and modern Maasai diets.
What Ethnobotanical Surveys Actually Show
The most comprehensive review of Maasai medicinal plants in Kenya combined 19 published sources and recorded 289 identified species with 1,844 use reports. Gastrointestinal complaints accounted for 27 percent of those reports and respiratory complaints for 14 percent.
ADVERTISEMENT
Decoction was the most frequently described preparation, oral use was common and roots were the most cited plant part (Nankaya et al., 2020, pp. 1, 4–5, 11–13).

Those numbers show breadth of knowledge, not 289 clinically approved medicines. A “use report” means that a source documented a plant being used for a stated purpose. It does not mean researchers proved the diagnosis, measured a standard dose or demonstrated effectiveness in human trials.
Plant name used in the source | Documented local use in a specific study | Evidence represented |
Vachellia nilotica | Digestive and upper-respiratory complaints among Loita participants | Ethnobotanical report |
Toddalia asiatica | Associated with malaria treatment in the Loita survey | Ethnobotanical report; the name now needs taxonomic updating |
Carissa spinarum | Diarrhoea, pelvic pain and backache in the Loita survey | Ethnobotanical report |
Commiphora africana | Used for suspected malaria by Maasai participants in the Arusha region | Traditional-use record followed by laboratory and mouse studies |
Dichrostachys cinerea | Used for suspected malaria in the same Tanzanian research | Traditional-use record followed by laboratory and mouse studies |
This is why an ethnobotanical table should never be copied into a home-treatment guide. It records culturally and scientifically important leads, but it does not provide safe recipes, doses or permission to delay professional care for malaria, pneumonia, severe diarrhoea, pregnancy complications or other potentially dangerous conditions.
Why Botanical Identification Is a Healthcare Issue
Local names carry deep ecological knowledge, but one vernacular name can sometimes refer to several related plants. The Sekenani researchers found that some Maa plant terms covered multiple species and noted that spelling varied because the names had been transmitted orally.
They collected specimens, processed them at the University of Nairobi Herbarium and deposited vouchers so later researchers could check the identification (Bussmann et al., 2006, pp. 3–4).

Scientific names also change. Royal Botanic Gardens, Kew currently treats Toddalia asiatica, the name used in several Maasai studies, as a synonym of Zanthoxylum asiaticum. A safe health programme therefore needs more than a photograph or translated plant name.
It needs a voucher specimen, collection location, expert identification, accepted scientific name and a record of the exact part harvested.
That discipline prevents substitution. Bark, root, leaf and fruit from the same species may contain different compounds, while similarly named species may have different safety profiles. Preparation, storage, contamination, season and plant age can also change the finished product. Botanical identification is therefore the first clinical safety barrier, not an academic decoration.
From Traditional Use to Medical Evidence
Traditional use is valuable evidence of experience and a rational starting point for research. It is not the final stage.
A medicinal plant can move through several levels: community documentation, verified identification, chemical analysis, laboratory testing, animal studies, human clinical trials, quality-controlled production and continuing monitoring for adverse effects.

A Tanzanian study shows both the promise and the limit. Researchers collected Commiphora africana and Dichrostachys cinerea in Monduli District, confirmed their identity at the Tanzania National Herbarium and deposited voucher specimens.
ADVERTISEMENT
Some extracts inhibited malaria parasites in laboratory tests and suppressed parasites in infected mice. One extract also showed weak cytotoxicity, and the authors called for further fractionation and advanced toxicity work (Kweyamba et al., 2019, “Methods,” “Results” and “Conclusion”).
That study did not prove that a household preparation cures malaria in people. Extracts made with laboratory solvents are not necessarily equivalent to a community decoction, and results in cells or mice cannot establish a human dose. The responsible conclusion is that Maasai knowledge identified research leads worth investigating not that malaria treatment should be replaced.
What Responsible Integration Could Look Like
The WHO Global Traditional Medicine Strategy 2025–2034 calls for stronger evidence, safety and regulation, appropriate integration into health systems and recognition of traditional medicine’s wider value. Applied locally, that direction could produce practical cooperation rather than symbolic celebration.

First, Maasai healers, knowledge holders and community health workers could help design referral pathways. A healer who recognises severe dehydration, breathing difficulty, altered consciousness, heavy bleeding or persistent fever should have a trusted route to a clinic.
Health workers, in turn, should ask respectfully about herbal use because possible side effects or herb–drug interactions cannot be managed when patients fear ridicule.
Second, agreed remedies selected for study should be documented consistently: accepted species, voucher number, plant part, preparation, route, intended use and known restrictions. Suspected adverse reactions should enter pharmacovigilance systems rather than remain invisible.
Third, products offered commercially need standards for identity, purity, strength, storage and labelling. Tanzania’s marketing-authorisation guidance for herbal medicinal products requires evidence addressing quality, safety and efficacy and identifies contamination, deterioration and inconsistent preparation as public-health risks (TMDA, 2020, pp. v–vii).
Fourth, integration must include culture without reducing every health decision to plants. Ideas about illness, wellbeing, prayer and specialist authority may intersect with the changes examined in XTRAfrica’s article on Maasai spirituality and Christianity. Care works better when professionals understand those realities instead of treating patients as empty recipients of instructions.
Finally, Maasai doctors, nurses, botanists, pharmacists, researchers and elders should lead the work together. Contemporary expertise already crosses rural and urban life, as shown in XTRAfrica’s profile of Maasai professionals balancing careers and heritage.
Conservation and Ownership Cannot Be Separated from Health
The Kenyan review found that roots were the most frequently cited plant part and warned that repeated root harvesting can threaten plant survival. In Loita, two-thirds of participants said medicinal plants were becoming harder to find. Reported pressures included drought, deforestation, population growth and lifestyle change, although community rules such as selective harvesting and temporary restrictions also supported conservation (Nankaya et al., 2020, pp. 2585–2586).
Land history is therefore part of medicine. Reduced access to forests, grazing areas and water can also reduce access to medicinal species. XTRAfrica’s investigation of Maasai land loss and the 1913 court case helps explain why present-day discussions about biodiversity cannot be detached from dispossession.
ADVERTISEMENT
TRENDING NOW
POPULAR TODAY
Knowledge ownership matters just as much. The Nagoya Protocol’s rules on traditional knowledge emphasise prior informed consent, mutually agreed terms and fair benefit-sharing when knowledge associated with genetic resources is used. Researchers should not publish restricted knowledge, collect plants or develop products first and discuss community benefits later. Consent, governance, authorship and benefit-sharing must begin before extraction.
Frequently Asked Questions
What are Maasai herbal remedies commonly used for?
Kenyan studies record uses associated with digestive and respiratory complaints, pain, wounds, dental hygiene, fever, malaria, pregnancy-related care and general strength. The pattern varies by locality, and documentation of use does not prove clinical effectiveness.
Are Maasai medicinal plants scientifically proven?
Some species or extracts have laboratory or animal evidence, but many records remain ethnobotanical. Few have completed the full pathway required for a standardised, clinically tested medicine. Evidence must be assessed plant by plant and preparation by preparation.
Can herbal remedies be taken with hospital medicines?
Not automatically. Herbs may change a medicine’s effect, add toxicity or complicate diagnosis. Patients should tell a qualified health professional what they have taken, and health workers should ask without dismissing or shaming them.
Why are voucher specimens important?
A voucher is a preserved, traceable plant specimen held in a recognised collection. It lets botanists verify which species researchers tested, especially when local names cover several plants or scientific names change.

Maasai herbal medicine deserves neither romantic praise nor automatic dismissal. It is a substantial body of community knowledge shaped by observation, landscape and generations of practice. Ethnobotanical surveys can identify priorities for research, strengthen culturally trusted care and reveal species that may contain useful compounds.
Integration becomes credible only when it protects patients and knowledge holders at the same time. Correct identification, clinical evidence, referral systems, quality control, conservation, consent and fair benefits are not obstacles to tradition.
They are the conditions under which Maasai knowledge can contribute to East African primary healthcare without being misused, depleted or stripped from the people who sustained it.
Sources and Reference
Bussmann, Rainer W., et al. 2006. “Plant Use of the Maasai of Sekenani Valley, Maasai Mara, Kenya.” Journal of Ethnobiology and Ethnomedicine 2:22.
Convention on Biological Diversity. “Nagoya Protocol on Access and Benefit-sharing and Traditional Knowledge.”
Kweyamba, Prisca A., et al. 2019. “In Vitro and In Vivo Studies on Anti-malarial Activity of Commiphora africana and Dichrostachys cinerea Used by the Maasai in Arusha Region, Tanzania.” Malaria Journal 18:119.
Nankaya, Jedidah, James Nampushi, Shani Petenya and Henrik Balslev. 2020. “Ethnomedicinal Plants of the Loita Maasai of Kenya.” Environment, Development and Sustainability 22:2569–2589.
Nankaya, Jedidah, Nathan Gichuki, Catherine Lukhoba and Henrik Balslev. 2020. “Medicinal Plants of the Maasai of Kenya: A Review.” Plants 9(1):44.
Royal Botanic Gardens, Kew. “Zanthoxylum asiaticum.” Plants of the World Online.
Tanzania Medicines and Medical Devices Authority. 2020. “Guidelines on Submission of Documentation for Marketing Authorization of Herbal Medicinal Products.”
World Health Organization. 2025. “Global Traditional Medicine Strategy 2025–2034.”
ADVERTISEMENT
RELATED ARTICLE

















